Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Inclusion of diverse populations: Future studies should aim to include more diverse populations, particularly in terms of age and ethnic groups, to ensure the generalizability of the findings
Here's the current landscape: Brand-Name Availability Mounjaro/Zepbound (tirzepatide): Eli Lilly has expanded manufacturing capacity
Mounjaro (tirzepatide), a dual GIP/GLP-1 receptor agonist, is licensed for type 2 diabetes and weight management
Most insurance providers require prior authorization in order to consider covering weight loss medications
US$ 29.64
US$ 26.51
US$ 21.31
US$ 29.26
